Zhitong Finance App News, Prodrug Pharmaceutical (000739.SZ) issued an announcement. Recently, Zhejiang Prodebon Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Notice of Approval of the Marketing Application for Chemical Ingredients” for cefetolampiride issued by the State Drug Administration (hereinafter referred to as the “Drug Administration”). The approval and listing of the company's cefotolempiride API indicates that the company has sales qualifications in the domestic market, broadened the company's product pipeline, helped further expand the company's API business, further promote the business development strategy for refined ingredients, and has certain positive significance for the company's future development.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.